(Q79236016)

English

Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study

scientific article published on 13 October 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Takashi Yana

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Shunichi Negoro

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Minoru Takada

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Soichiro Yokota

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Yoshiki Takada

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Takahiko Sugiura

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Hidehiko Yamamoto

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Masaaki Kawahara

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Nobuyuki Katakami

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Yutaka Ariyoshi

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Masahiro Fukuoka

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

West Japan Thoracic Oncology Group

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

13 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

253-258

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039404%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

https://scigraph.springernature.com/pub.10.1007/s10637-006-9012-9

0 references

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic effects of a novel synthetic anthracycline derivative (SM-5887) on normal heart and doxorubicin-induced cardiomyopathy in beagle dogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/17039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiotoxicity of a new anthracycline derivative (SM-5887) following intravenous administration to rabbits: comparative study with doxorubicin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo efficacy and tumor-selective metabolism of amrubicin to its active metabolite.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicological aspects of a novel 9-aminoanthracycline, SM-5887.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new antitumor agent amrubicin induces cell growth inhibition by stabilizing topoisomerase II-DNA complex.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extensive-disease small-cell lung cancer: the thrill of victory; the agony of defeat

1 reference

https://pubmed.ncbi.nlm.nih.gov/17039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-agent chemotherapy trials in small-cell lung cancer, 1970 to 1990: the case for studies in previously treated patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activities of a novel 9-aminoanthracycline (SM-5887) against mouse experimental tumors and human tumor xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/17039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxicity of amrubicin, a novel 9-aminoanthracycline, and its active metabolite amrubicinol on human tumor cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop

1 reference

https://pubmed.ncbi.nlm.nih.gov/17039404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79236016&oldid=1760202287"